General & Plastic Surgery Devices - G20

  • G20
  • In the G20, the revenue in the General & Plastic Surgery Devices market market is estimated to reach US$22.65bn by 2024.
  • It is anticipated that the revenue will experience a compound annual growth rate (CAGR) of 5.33% from 2024 to 2029, leading to a market volume of US$29.36bn by 2029.
  • When compared globally, the United States is expected to generate the highest revenue of US$9,844.00m in 2024.
  • In the G20 country of Brazil, there is a growing trend in the General & Plastic Surgery Devices market as more individuals seek cosmetic enhancements to enhance their appearance.

Key regions: Europe, Japan, United Kingdom, Netherlands, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The General & Plastic Surgery Devices market in G20 is experiencing significant growth and development due to several factors. Customer preferences for cosmetic procedures and advancements in technology are driving the demand for these devices. Additionally, local special circumstances and underlying macroeconomic factors are contributing to the market's growth. Customer preferences play a crucial role in the development of the General & Plastic Surgery Devices market in G20. There is a growing demand for cosmetic procedures, both for medical and aesthetic purposes. People are increasingly opting for surgical and non-surgical procedures to enhance their appearance or correct physical abnormalities. This rising demand is driving the need for advanced and innovative devices that can provide effective and safe solutions. Advancements in technology are also fueling the growth of the General & Plastic Surgery Devices market in G20. The development of minimally invasive procedures and the introduction of new surgical techniques have revolutionized the field of plastic surgery. These advancements have led to the creation of sophisticated devices that can deliver precise and efficient results. Customers are increasingly seeking out these advanced devices to ensure optimal outcomes and minimize risks. In addition to customer preferences and technological advancements, there are local special circumstances that are shaping the General & Plastic Surgery Devices market in G20. Each country within the G20 has its own unique cultural and social factors that influence the demand for cosmetic procedures. For example, countries with a strong emphasis on beauty and youthfulness may have a higher demand for these devices. Furthermore, the availability of skilled medical professionals and the presence of specialized clinics and hospitals also impact the market's development. Underlying macroeconomic factors are also contributing to the growth of the General & Plastic Surgery Devices market in G20. Economic prosperity and rising disposable incomes enable individuals to afford cosmetic procedures. As economies within the G20 continue to develop, more people have the financial means to invest in these treatments. Additionally, favorable government policies and regulations regarding cosmetic procedures also play a role in the market's expansion. Overall, the General & Plastic Surgery Devices market in G20 is experiencing growth and development due to customer preferences, technological advancements, local special circumstances, and underlying macroeconomic factors. As the demand for cosmetic procedures continues to rise and technology continues to advance, the market is expected to further expand in the coming years.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Overview

  • Revenue
  • Key Players
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)